FDA approves new treatment for sickle cell disease - FDA Press Releases

The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood disorder.

from Food and Drug Administration--Press Releases http://ift.tt/2sUL2xL
via IFTTT